We are live on
!
Find out more
PP
Paloma Partners Portfolio holdings
AUM
$510M
1-Year Est. Return
286.05%
This Fund
S&P 500
This Quarter
Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
(-13%)
Cap. Flow
-$699M
Cap. Flow
% of AUM
-18.5%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$28.7M |
| 2 |
Invesco CurrencyShares Euro Currency Trust
FXE
|
+$23.2M |
| 3 |
Biogen
BIIB
|
+$20.8M |
| 4 |
Nike
NKE
|
+$18.3M |
| 5 |
IBM
IBM
|
+$17.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$48.6M |
| 2 |
JPMorgan Chase
JPM
|
+$47.9M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$46.2M |
| 4 |
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
|
+$31.6M |
| 5 |
Kimco Realty
KIM
|
+$26.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.62% |
| 2 | Industrials | 6.54% |
| 3 | Financials | 6.19% |
| 4 | Technology | 6.15% |
| 5 | Consumer Discretionary | 5.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1551
PUT
HP
HPQ
$25.9B
| $189K | 0.01% |
16,000
-19,232
| -55% | -$246K |
|
|
AF
1552
DELISTED
Astoria Financial Corporation
AF
| $189K | 0.01% |
11,974
-4,326
| -27% | -$70.3K |
|
|
FBR
1553
DELISTED
Fibria Celulose Sa
FBR
| $188K | 0.01% |
+14,770
| New | +$202K |
|
|
GTT
1554
DELISTED
GTT Communications, Inc.
GTT
| $186K | ﹤0.01% |
+10,859
| New | +$216K |
|
1555
Clean Energy Fuels
CLNE
$421M
| $184K | ﹤0.01% |
+50,869
| New | +$244K |
|
|
AUY
1556
DELISTED
Yamana Gold, Inc.
AUY
| $184K | ﹤0.01% |
+99,373
| New | +$207K |
|
1557
Olin
OLN
$2.44B
| $183K | ﹤0.01% |
10,629
+113
| +1% | +$2.17K |
|
|
BDSI
1558
DELISTED
BioDelivery Sciences International, Inc.
BDSI
| $181K | ﹤0.01% |
+37,853
| New | +$215K |
|
|
SHOR
1559
DELISTED
ShoreTel, Inc.
SHOR
| $180K | ﹤0.01% |
+20,363
| New | +$189K |
|
|
KATE
1560
DELISTED
Kate Spade & Company
KATE
| $180K | ﹤0.01% |
+10,115
| New | +$198K |
|
1561
SLM Corp
SLM
$4.74B
| $177K | ﹤0.01% |
27,100
-14,801
| -35% | -$100K |
|
1562
Patterson-UTI
PTEN
$3.48B
| $171K | ﹤0.01% |
+11,300
| New | +$174K |
|
1563
Teck Resources
TECK
$28.8B
| $168K | ﹤0.01% |
43,500
+26,794
| +160% | +$133K |
|
|
SN
1564
DELISTED
Sanchez Energy Corporation
SN
| $168K | ﹤0.01% |
+39,007
| New | +$220K |
|
1565
Annaly Capital Management
NLY
$17.4B
| $167K | ﹤0.01% |
4,458
-625
| -12% | -$24.4K |
|
|
FOE
1566
DELISTED
Ferro Corporation
FOE
| $166K | ﹤0.01% |
14,929
-21,358
| -59% | -$253K |
|
|
LFC
1567
DELISTED
China Life Insurance Company Ltd.
LFC
| $164K | ﹤0.01% |
10,242
-8,164
| -44% | -$145K |
|
|
MDR
1568
DELISTED
McDermott International
MDR
| $164K | ﹤0.01% |
16,291
+8,752
| +116% | +$120K |
|
1569
Northern Oil and Gas
NOG
$2.16B
| $156K | ﹤0.01% |
+4,029
| New | +$192K |
|
|
RATE
1570
DELISTED
Bankrate Inc
RATE
| $155K | ﹤0.01% |
11,686
-50,261
| -81% | -$664K |
|
1571
Sunstone Hotel Investors
SHO
$2.19B
| $154K | ﹤0.01% |
+12,379
| New | +$175K |
|
|
CRC
1572
DELISTED
California Resources Corporation
CRC
| $152K | ﹤0.01% |
6,540
+1,380
| +27% | +$49.7K |
|
|
SVA
1573
DELISTED
Sinovac Biotech, Ltd
SVA
| $151K | ﹤0.01% |
+26,456
| New | +$142K |
|
1574
Hudbay
HBM
$9.67B
| $148K | ﹤0.01% |
+38,413
| New | +$172K |
|
1575
Sibanye-Stillwater
SBSW
$5.93B
| $143K | ﹤0.01% |
24,850
-157,513
| -86% | -$883K |
|
Similar funds
PWMG
NIEF
HIM
MCA
OA
MC
CTAF
MWAM
Paloma Partners's Q4 2015 Portfolio in Review
As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.
Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.
- Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
- Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
- Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
- Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
- Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
- Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
- Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.
Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.